{"id":"W2563880171","doi":"10.1182/blood.v114.22.3829.3829","title":"Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Medicine; Tolerability; Myelodysplastic syndromes; International Prognostic Scoring System; Internal medicine; Creatinine; Adverse effect; Anemia; Ferritin; Gastroenterology; Pediatrics; Surgery; Thalassemia; Bone marrow","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004213419,0.0005226514,0.0009800185,0.0004262601,0.0003456685,0.000646743,0.0004665691,0.0009505406,0.001385551],"category_scores_gemma":[0.002562328,0.0002953488,0.001386583,0.0005617097,0.0003684393,0.0006061575,0.0003097958,0.001232667,0.0003067463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006164795,"about_ca_system_score_gemma":0.0006993188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001778263,"about_ca_topic_score_gemma":0.002028325,"domain_scores_codex":[0.9990338,0.0004862245,0.00007953741,0.0001202972,0.0001226554,0.000157432],"domain_scores_gemma":[0.9970213,0.0006903548,0.0009807135,0.0001980009,0.0002858417,0.0008238432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5447204,0.00901502,0.3869131,0.0002781086,0.002143295,0.0004882317,0.0003059498,0.001581744,0.01073763,0.0001185298,0.002082337,0.04161577],"study_design_scores_gemma":[0.02872992,0.1572531,0.8062432,0.0000444336,0.001403784,0.000448547,0.000127861,0.002098779,0.001861134,0.00008531882,0.001649963,0.00005395635],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977635,0.0009246791,0.0001015907,0.00004837705,0.00001329296,0.0001088095,0.0005742287,0.00001083629,0.0004545585],"genre_scores_gemma":[0.9980617,0.0001405877,0.00009777898,0.0001008641,0.00002945569,0.00008164887,0.001193237,0.000003500975,0.0002911207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004213419,"threshold_uncertainty_score":0.02228296,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01341310169299307,"score_gpt":0.289840718610845,"score_spread":0.2764276169178519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}